Skip to main content

Traumatic Brain Injury (TBI)

0
Pipeline Programs
4
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Oregon Therapeutics
Oregon TherapeuticsFrance - Paris
1 program
AIMN/A1 trial
Active Trials
NCT01779427Withdrawn0Est. Jan 2014
Baxter International
1 program
Hemodynamic ABI MonitorN/A
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
divalproex sodiumN/A1 trial
Active Trials
NCT01760785Completed50Est. Jun 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Oregon TherapeuticsAIM
Colorado Therapeuticsdivalproex sodium

Clinical Trials (2)

Total enrollment: 50 patients across 2 trials

Attention Intervention Management

Start: Jan 2013Est. completion: Jan 20140
N/AWithdrawn

Valproate for Mood Swings and Alcohol Use Following Head Injury

Start: Sep 2008Est. completion: Jun 201650 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.